<?xml version="1.0" encoding="UTF-8"?>
<p>In addition, the OMVs-H1/RBD vaccinated mice showed a significant increase of neutralizing antibodies against the MERS-CoV strain HKU-NRCE-270 at week 2 and reached the highest neutralizing titer 160 (7.3 log2) at week eight compared to the control group (
 <italic>p</italic> &lt; 0.001) (
 <xref ref-type="fig" rid="vaccines-07-00046-f002">Figure 2</xref>c and 
 <xref ref-type="fig" rid="vaccines-07-00046-f003">Figure 3</xref>a). Control (1× PBS), inactivated H1N1pdm2009 and OMVs-empty groups showed no neutralizing antibodies against MERS-CoV during the eight weeks of infection (
 <xref ref-type="fig" rid="vaccines-07-00046-f003">Figure 3</xref>b–d).
</p>
